Neutralization of oxidized phospholipids attenuates age-associated bone loss in mice
© 2021 The Authors. Aging Cell published by Anatomical Society and John Wiley & Sons Ltd..
Oxidized phospholipids (OxPLs) are pro-inflammatory molecules that affect bone remodeling under physiological conditions. Transgenic expression of a single-chain variable fragment (scFv) of the antigen-binding domain of E06, an IgM natural antibody that recognizes the phosphocholine (PC) moiety of OxPLs, increases trabecular and cortical bone in adult male and female mice by increasing bone formation. OxPLs increase with age, while natural antibodies decrease. Age-related bone loss is associated with increased oxidative stress and lipid peroxidation and is characterized by a decline in osteoblast number and bone formation, raising the possibility that increased OxPLs, together with the decline of natural antibodies, contribute to age-related bone loss. We show here that transgenic expression of E06-scFv attenuated the age-associated loss of spinal, femoral, and total bone mineral density in both female and male mice aged up to 22 and 24 months, respectively. E06-scFv attenuated the age-associated decline in trabecular bone, but not cortical bone, and this effect was associated with an increase in osteoblasts and a decrease in osteoclasts. Furthermore, RNA-seq analysis showed that E06-scFv increased Wnt10b expression in vertebral bone in aged mice, indicating that blocking OxPLs increases Wnt signaling. Unlike age-related bone loss, E06-scFv did not attenuate the bone loss caused by estrogen deficiency or unloading in adult mice. These results demonstrate that OxPLs contribute to age-associated bone loss. Neutralization of OxPLs, therefore, is a promising therapeutic target for senile osteoporosis, as well as atherosclerosis and non-alcoholic steatohepatitis (NASH), two other conditions shown to be attenuated by E06-scFv in mice.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
|---|---|
| Enthalten in: |
Aging cell - 20(2021), 8 vom: 02. Aug., Seite e13442 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Palmieri, Michela [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 31.01.2022 Date Revised 31.01.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/acel.13442 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM32824063X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM32824063X | ||
| 003 | DE-627 | ||
| 005 | 20231225202535.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/acel.13442 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1094.xml |
| 035 | |a (DE-627)NLM32824063X | ||
| 035 | |a (NLM)34278710 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Palmieri, Michela |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Neutralization of oxidized phospholipids attenuates age-associated bone loss in mice |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 31.01.2022 | ||
| 500 | |a Date Revised 31.01.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2021 The Authors. Aging Cell published by Anatomical Society and John Wiley & Sons Ltd. | ||
| 520 | |a Oxidized phospholipids (OxPLs) are pro-inflammatory molecules that affect bone remodeling under physiological conditions. Transgenic expression of a single-chain variable fragment (scFv) of the antigen-binding domain of E06, an IgM natural antibody that recognizes the phosphocholine (PC) moiety of OxPLs, increases trabecular and cortical bone in adult male and female mice by increasing bone formation. OxPLs increase with age, while natural antibodies decrease. Age-related bone loss is associated with increased oxidative stress and lipid peroxidation and is characterized by a decline in osteoblast number and bone formation, raising the possibility that increased OxPLs, together with the decline of natural antibodies, contribute to age-related bone loss. We show here that transgenic expression of E06-scFv attenuated the age-associated loss of spinal, femoral, and total bone mineral density in both female and male mice aged up to 22 and 24 months, respectively. E06-scFv attenuated the age-associated decline in trabecular bone, but not cortical bone, and this effect was associated with an increase in osteoblasts and a decrease in osteoclasts. Furthermore, RNA-seq analysis showed that E06-scFv increased Wnt10b expression in vertebral bone in aged mice, indicating that blocking OxPLs increases Wnt signaling. Unlike age-related bone loss, E06-scFv did not attenuate the bone loss caused by estrogen deficiency or unloading in adult mice. These results demonstrate that OxPLs contribute to age-associated bone loss. Neutralization of OxPLs, therefore, is a promising therapeutic target for senile osteoporosis, as well as atherosclerosis and non-alcoholic steatohepatitis (NASH), two other conditions shown to be attenuated by E06-scFv in mice | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Research Support, U.S. Gov't, Non-P.H.S. | |
| 650 | 4 | |a Wnt signaling | |
| 650 | 4 | |a aging and bone | |
| 650 | 4 | |a osteoblasts | |
| 650 | 4 | |a oxidized phospholipids | |
| 650 | 7 | |a Phospholipids |2 NLM | |
| 700 | 1 | |a Almeida, Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Nookaew, Intawat |e verfasserin |4 aut | |
| 700 | 1 | |a Gomez-Acevedo, Horacio |e verfasserin |4 aut | |
| 700 | 1 | |a Joseph, Teenamol E |e verfasserin |4 aut | |
| 700 | 1 | |a Que, Xuchu |e verfasserin |4 aut | |
| 700 | 1 | |a Tsimikas, Sotirios |e verfasserin |4 aut | |
| 700 | 1 | |a Sun, Xiaoli |e verfasserin |4 aut | |
| 700 | 1 | |a Manolagas, Stavros C |e verfasserin |4 aut | |
| 700 | 1 | |a Witztum, Joseph L |e verfasserin |4 aut | |
| 700 | 1 | |a Ambrogini, Elena |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Aging cell |d 2002 |g 20(2021), 8 vom: 02. Aug., Seite e13442 |w (DE-627)NLM126391149 |x 1474-9726 |7 nnns |
| 773 | 1 | 8 | |g volume:20 |g year:2021 |g number:8 |g day:02 |g month:08 |g pages:e13442 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/acel.13442 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 20 |j 2021 |e 8 |b 02 |c 08 |h e13442 | ||